Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,780,541
  • Shares Outstanding, K 15,117
  • Annual Sales, $ 2,264 M
  • Annual Income, $ 272,510 K
  • 60-Month Beta 0.42
  • Price/Sales 4.34
  • Price/Cash Flow 26.47
  • Price/Book 8.84
Trade CHE with:

Options Overview Details

View History
  • Implied Volatility 15.97% ( -0.16%)
  • Historical Volatility 23.80%
  • IV Percentile 18%
  • IV Rank 15.22%
  • IV High 24.85% on 04/18/23
  • IV Low 14.38% on 12/21/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 127
  • Open Int (30-Day) 224

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 5.26
  • Number of Estimates 2
  • High Estimate 5.47
  • Low Estimate 5.06
  • Prior Year 4.39
  • Growth Rate Est. (year over year) +19.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
582.20 +11.48%
on 02/20/24
654.62 -0.85%
on 03/15/24
+65.61 (+11.25%)
since 02/16/24
3-Month
564.10 +15.06%
on 01/05/24
654.62 -0.85%
on 03/15/24
+71.40 (+12.36%)
since 12/18/23
52-Week
492.84 +31.69%
on 09/13/23
654.62 -0.85%
on 03/15/24
+134.34 (+26.10%)
since 03/17/23

Most Recent Stories

More News
Chemed: Q4 Earnings Snapshot

Chemed: Q4 Earnings Snapshot

CHE : 649.04 (+0.32%)
Chemed: Q3 Earnings Snapshot

Chemed: Q3 Earnings Snapshot

CHE : 649.04 (+0.32%)
Chemed: Q2 Earnings Snapshot

Chemed: Q2 Earnings Snapshot

CHE : 649.04 (+0.32%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 137.02 (+0.27%)
CHE : 649.04 (+0.32%)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore...

CHE : 649.04 (+0.32%)
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View

AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.

ISRG : 392.62 (-0.92%)
ABC : 179.98 (-0.23%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves

Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.

SYK : 354.08 (+0.53%)
ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong

DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
DXCM : 134.72 (+3.27%)
CHE : 649.04 (+0.32%)
Baxter (BAX) Beats on Q1 Earnings, Ups '23 EPS View

Baxter's (BAX) first-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.

BAX : 41.54 (-0.17%)
ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
CHE : 649.04 (+0.32%)
West Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong

West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.

ISRG : 392.62 (-0.92%)
EW : 92.85 (+0.58%)
WST : 395.72 (+2.09%)
CHE : 649.04 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 659.64
2nd Resistance Point 656.43
1st Resistance Point 652.73
Last Price 649.04
1st Support Level 645.82
2nd Support Level 642.61
3rd Support Level 638.91

See More

52-Week High 654.62
Last Price 649.04
Fibonacci 61.8% 592.82
Fibonacci 50% 573.73
Fibonacci 38.2% 554.64
52-Week Low 492.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar